Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
270 results found
2019 ∙ Sings, H. L. De Wals, P. Gessner, B. D. Isturiz, R. Laferriere, C. McLaughlin, J. M. Pelton, S. Schmitt, H. J. Suaya, J. A. Jodar, L.
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
Newborn Children Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Critically low
2019 ∙ Vardanjani, H. M. Borna, H. Ahmadi, A.
Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2019 ∙ Ngocho, J. S. Magoma, B. Olomi, G. A. Mahande, M. J. Msuya, S. E. de Jonge, M. I. Mmbaga, B. T.
Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review
Africa All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2019 ∙ Adawi, M. Bragazzi, N. L. McGonagle, D. Watad, S. Mahroum, N. Damiani, G. Conic, R. Bridgewood, C. Mahagna, H. Giacomelli, L. Eggenhoffner, R. Mahamid, M. Pigatto, P. D. M. Amital, H. Watad, A.
Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis
All age groups Pneumococcal disease Efficacy/effectiveness Safety
Rating:
Critically low
2019 ∙ Vadlamudi, N. K. Chen, A. Marra, F.
Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration Coverage
Rating:
Critically low
2019 ∙ McLaughlin, J. M. Jiang, Q. Gessner, B. D. Swerdlow, D. L. Sings, H. L. Isturiz, R. E. Jodar, L.
Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2019 ∙ Fu, J. Yi, R. Jiang, Y. Xu, S. Qin, P. Liang, Z. Chen, J.
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis
Western Pacific China Newborn Children Adolescents Pneumococcal disease Coverage
Rating:
Not applicable
2019 ∙ Chiappini, E. Petrolini, C. Sandini, E. Licari, A. Pugni, L. Mosca, F. A. Marseglia, G. L.
Update on vaccination of preterm infants: a systematic review about safety and efficacy/effectiveness. Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology
Newborn Pneumococcal disease Influenza Hepatitis B Poliomyelitis Safety Efficacy/effectiveness
Rating:
Critically low
2019 ∙ Adetokunboh, O. O. Ndwandwe, D. Awotiwon, A. Uthman, O. A. Wiysonge, C. S.
Vaccination among HIV-infected, HIV-exposed uninfected and HIV-uninfected children: a systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness
Africa Newborn Children Adolescents Rotavirus Pneumococcal disease Haemophilus influenzae type B Tuberculosis Hepatitis B Efficacy/effectiveness
Rating:
Critically low
2019 ∙ Conseil Supérieur des Maladies Infectieuses
recommendations concerning the vaccination of children born prematurely
Recommendation Europe Luxembourg Children Newborn Risk group Pneumococcal disease Hepatitis B Influenza
Download:
Loading...